Andrew J. Murphy - 16 Dec 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP Research
Signature
/s/ Andrew Murphy
Issuer symbol
REGN
Transactions as of
16 Dec 2024
Net transactions value
-$770,274
Form type
4
Filing time
18 Dec 2024, 16:02:34 UTC
Previous filing
10 Dec 2024
Next filing
31 Oct 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Tax liability $770,274 -1,054 -2.1% $730.81 49,074 16 Dec 2024 Direct
holding REGN Common Stock 4,326 16 Dec 2024 By 401(k) Plan
* An asterisk sign (*) next to the price indicates that the price is likely invalid.